Skip to content

Evaluation of MUSA-3 in Microsurgical Anastomoses

Clinical Safety and Performance Evaluation of MUSA-3 in Microsurgical Anastomoses

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07427823
Enrollment
30
Registered
2026-02-23
Start date
2026-04-20
Completion date
2026-09-28
Last updated
2026-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomosis, Surgical

Brief summary

This study is conducted to evaluate the safety and performance of robot-assisted microsurgical anastomoses with the MUSA-3 system.

Interventions

DEVICERobot-assisted microsurgical anastomoses

First in human study

Sponsors

Microsure
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient age ≥ 18 years. * Patients requiring procedures involving micro-anastomosis of small anatomical structures-such as blood vessels, nerves, or lymphatic vessels-in free flap, lymphatic, or peripheral nerve surgery. * Patients who have been selected by the research team at the Clinical Center as appropriate candidates for treatment with MUSA-3 in accordance with the IFU. * Able to give informed consent before participating in the study. * Provision of signed and dated informed consent form.

Exclusion criteria

* Subject participates in a potentially confounding drug or device trial during the course of the study. * Patients that are pregnant or breastfeeding. For Lymphedema patients: * ≥ISL (International Society of Lymphology) Stage III lymphedema * History of marcaine or indocyanine green allergy * Non-viable lymphatic system as determined by ICG lymphatic mapping using near infrared camera

Design outcomes

Primary

MeasureTime frame
Safety: device-related adverse events (AEs)Intraoperatively and through the 30-day post-procedure period
Performance: conversion rate to manual procedureIntraoperatively
Clinical performance: vessel patency rateIntraoperatively

Secondary

MeasureTime frameDescription
Anastomosis quality (SAMS score)IntraoperativelyThe quality of the anastomosis assessed with the Structured Assessment of Microsurgery Skills (SAMS) score.
Anastomosis timeIntraoperativelyDuration of the full anastomosis from the moment of piercing the vessel wall for the first stitch until the thread of the last stitch is cut.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026